The Role of Presepsin as a Biomarker of Sepsis in Children: A Systemic Review and Meta-Analysis

Objectives: Biomarkers in sepsis are an arena of avid research as they can facilitate timely diagnosis and help reduce mortality. Presepsin is a promising candidate with good diagnostic performance reported in adult and neonatal studies. However, there is no clear consensus about its utility in the pediatric age group. This study aimed to synthesis scientific evidence regarding the diagnostic and prognostic performance of presepsin in pediatric sepsis. Data Sources: A systematic literature search was conducted in MEDLINE/PubMed, Cochrane Central Register of Clinical Trials, Google Scholar, and Scopus to identify relevant studies reporting the diagnostic and prognostic accuracy of presepsin. Study Selection: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we retrieved all controlled trials and observational studies on presepsin as a biomarker in children aged <19 years with sepsis. Data Extraction: Two authors independently performed study>screening, data extraction, and quality assessment of the included studies. Data Synthesis: Among the 267 citations identified, a total of nine relevant studies were included in the final analysis. The pooled diagnostic sensitivity and specificity of presepsin were 0.99 (95% confidence interval [CI]; 0.97–1.00) and 0.88 (95% CI; 0.83–0.92), respectively with a Diagnostic Odds Ratio (DOR) of 28.15 (95% CI; 0.74–1065.67) and Area Under the Curve (AUC) in Summary Receiver Operating Curve(SROC) of 0.89. Prognostic accuracy for presepsin had a sensitivity of 0.64 (95% CI; 0.35–1.0), specificity of 0.62 (95% CI; 0.44–0.87), and DOR of 3.3 (95% CI; 0.20–53.43). For procalcitonin (PCT), the pooled sensitivity for diagnostic accuracy was 0.97 (95% CI; 0.94–1.00), specificity was 0.76 (95% CI; 0.69–0.82), DOR was 10.53 (95% CI; 5.31–20.88) and AUC was 0.81. Conclusion: Presepsin has good diagnostic accuracy with high sensitivity and specificity. Its prognostic accuracy in predicting mortality is low.

Authors

Publication Details

Journal
Journal of Pediatric Intensive Care
Published
2026-03-12
DOI
https://doi.org/10.53391/2146-4618.1064
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Role of Presepsin as a Biomarker of Sepsis in Children: A Systemic Review and Meta-Analysis

Daisy Khera, Ankita Chugh, Nisha Toteja, Siyaram Didel et al.
Journal of Pediatric Intensive Care
Sepsis Diagnosis and Treatment
article

The Role of Presepsin as a Biomarker of Sepsis in Children: A Systemic Review and Meta-Analysis

Daisy Khera, Ankita Chugh, Nisha Toteja, Siyaram Didel, Simranjeet Singh, Kuldeep Singh, Surjit Singh
article en

Abstract

Objectives: Biomarkers in sepsis are an arena of avid research as they can facilitate timely diagnosis and help reduce mortality. Presepsin is a promising candidate with good diagnostic performance reported in adult and neonatal studies. However, there is no clear consensus about its utility in the pediatric age group. This study aimed to synthesis scientific evidence regarding the diagnostic and prognostic performance of presepsin in pediatric sepsis. Data Sources: A systematic literature search was conducted in MEDLINE/PubMed, Cochrane Central Register of Clinical Trials, Google Scholar, and Scopus to identify relevant studies reporting the diagnostic and prognostic accuracy of presepsin. Study Selection: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we retrieved all controlled trials and observational studies on presepsin as a biomarker in children aged <19 years with sepsis. Data Extraction: Two authors independently performed study>screening, data extraction, and quality assessment of the included studies. Data Synthesis: Among the 267 citations identified, a total of nine relevant studies were included in the final analysis. The pooled diagnostic sensitivity and specificity of presepsin were 0.99 (95% confidence interval [CI]; 0.97–1.00) and 0.88 (95% CI; 0.83–0.92), respectively with a Diagnostic Odds Ratio (DOR) of 28.15 (95% CI; 0.74–1065.67) and Area Under the Curve (AUC) in Summary Receiver Operating Curve(SROC) of 0.89. Prognostic accuracy for presepsin had a sensitivity of 0.64 (95% CI; 0.35–1.0), specificity of 0.62 (95% CI; 0.44–0.87), and DOR of 3.3 (95% CI; 0.20–53.43). For procalcitonin (PCT), the pooled sensitivity for diagnostic accuracy was 0.97 (95% CI; 0.94–1.00), specificity was 0.76 (95% CI; 0.69–0.82), DOR was 10.53 (95% CI; 5.31–20.88) and AUC was 0.81. Conclusion: Presepsin has good diagnostic accuracy with high sensitivity and specificity. Its prognostic accuracy in predicting mortality is low.

Journal of Pediatric Intensive CareVol. 14(6)
McMaster University
Zero hunger
Openalex Percentile: Top 23%
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.